Improved diagnostic accuracy of blood tests for severe fibrosis and cirrhosis in chronic hepatitis C

European Journal of Gastroenterology and Hepatology

Volumn 21, Issue 1, 2009, Pages 28-38

  Boursier, Jérôme ^a   Bacq, Yannick ^b   Halfon, Philippe ^c   Leroy, Vincent ^e   De Ledinghen, Victor ^g,h   De Muret, Anne ^b   Bourlière, Marc ^d   Sturm, Nathalie ^f   Foucher, Juliette ^g,h   Oberti, Frédéric ^a   Rousselet, Marie Christine ^a   Calès, Paul ^a,i  

^a CH and U   (France)

^b SERVICE DE DERMATOLOGIE   (France)

^c Laboratoire Alphabio   (France)

^d HÔPITAL SAINT JOSEPH   (France)

^e UNIV GRENOBLE ALPES   (France)

^f GRENOBLE UNIVERSITY HOSPITAL   (France)

^g HAUT LÉVÊQUE HOSPITAL   (France)

^h BORDEAUX UNIVERSITY HOSPITAL   (France)

ⁱ ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

Blood markers; Cirrhosis; Diagnostic accuracy; Liver biopsy; Liver fibrosis; Metavir staging; Noninvasive diagnosis; Sensitivity; Specificity; Viral hepatitis C

Indexed keywords

ASPARTATE AMINOTRANSFERASE;

ADULT; ARTICLE; BLOOD EXAMINATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

ADULT; BIOLOGICAL MARKERS; BIOPSY, NEEDLE; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY;

EID: 58149218312     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32830cebd7     Document Type: Article

References (29)

1. Oberti F, Valsesia E, Pilette C, Rousselet MC, Bedossa P, Aube C, et al. Noninvasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology 1997; 113:1609-1616.
2. Sebastiani G, Alberti A. Noninvasive fibrosis biomarkers reduce but not substitute the need for liver biopsy. World J Gastroenterol 2006; 12:3682-3694.
3. Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005; 128:343-350.
4. Cales P, Oberti F, Michalak S, Hubert-Fouchard I, Rousselet MC, Konate A, et al. A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology 2005; 42:1373-1381.
5. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38:518-526.
6. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001; 357:1069-1075.
7. Adams LA, Bulsara M, Rossi E, DeBoer B, Speers D, George J, et al. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem 2005; 51:1867-1873.
8. Halfon P, Bacq Y, De Muret A, Penaranda G, Bourliere M, Ouzan D, et al. Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C. J Hepatol 2007; 46:395-402.
9. Leroy V, Hilleret MN, Sturm N, Trocme C, Renversez JC, Faure P, et al. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C. J Hepatol 2007; 46:775-782.
10. Halfon P, Imbert-Bismut F, Messous D, Antoniotti G, Benchetrit D, Cart-Lamy P, et al. A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease. Comp Hepatol 2002; 1:3.
11. Cales P, Veillon P, Konate A, Mathieu E, Ternisien C, Chevallier A, et al. Reproducibility of blood tests of liver fibrosis in clinical practice. Clin Biochem 2008; 41:10-18.
12. Calès P, De Ledinghen V, Halfon P, Bacq Y, Leroy V, Boursier J, et al. Evaluating accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C. Liver Int 2008; (in press).
13. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 1994; 20:15-20.
14. Greenhalgh T. How to read a paper. Papers that report diagnostic or screening tests. Br Med J 1997; 315:540-543.
15. Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 2003; 56:1129-1135.
16. Parkes J, Guha IN, Roderick P, Rosenberg W. Performance of serum marker panels for liver fibrosis in chronic hepatitis C. J Hepatol 2006; 44:462-474.
17. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44:837-845.
18. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem 2003; 49:7-18.
19. Calès P, Halfon P, Bacq Y, Leroy V, Rousselet MC, Bourliere M, et al. Meta-analysis of blood scores for liver fibrosis in chronic hepatitis C. Hepatology 2006; 44:279A.
20. Rousselet MC, Michalak S, Dupre F, Croue A, Bedossa P, Saint-Andre JP, Cales P. Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 2005; 41:257-264.
21. Leroy V, Halfon P, Bacq Y, Boursier J, Rousselet M, Bourliere M, et al. Diagnostic accuracy, reproducibility and robustness of fibrosis blood tests in chronic hepatitis C: a meta-analysis with individual data. Clin Biochem 2008; (in press).
22. Cacoub P, Carrat F, Bedossa P, Lambert J, Penaranda G, Perronne C, et al. Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic study-ANRS HC02. J Hepatol 2008; 48:765-773.
23. Leroy V, Sturm N, Hilleret M, Renversez P, Trocme C, Faure P, Zarski J. Diagnostic accuracy of blood tests of liver fibrosis in chronic hepatitis B: comparison with hepatitis C. Hepatology 2007; 46:900-901.
24. Sebastiani G, Vario A, Guido M, Noventa F, Plebani M, Pistis R, et al. Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C. J Hepatol 2006; 44:686-693.
25. Shaheen AA, Myers RP. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review. Hepatology 2007; 46:912-921.
26. Kim BK, Kim SA, Park YN, Cheong JY, Kim HS, Park JY, et al. Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B. Liver Int 2007; 27:969-976.
27. Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venier V, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology 2007; 46:32-36.
28. Colletta C, Smirne C, Fabris C, Toniutto P, Rapetti R, Minisini R, Pirisi M. Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases. Hepatology 2005; 42:838-845.
29. Poynard T, Munteanu M, Ngo Y, Torres M, Benhamou Y, Thabut D, Ratziu V. Diagnostic value of FibroTest with normal serum aminotransferases. Hepatology 2006; 43:374-375.